A recent article posted to the bioRxiv* preprint server analyzed multivalent messenger ribonucleic acid (mRNA)-lipid nanoparticle (LNP) vaccine constructs against certain β-coronaviruses (β-CoVs).
Since the beginning of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-induced pandemic of coronavirus disease 2019 (COVID-19), effective and safe antivirals are being sought with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback